The Life sciences industry operates at the intersection of scientific innovation, regulatory oversight, and commercial risk. Pharmaceutical, biotechnology, and medical device companies must simultaneously advance research, secure funding, comply with stringent global regulations, and prepare for successful commercialization. In this complex environment, strategic misalignment can lead... https://ziondinsx.wikigop.com/189014/why_bioboston_consulting_is_a_strategic_partner_for_life_sciences_innovation